These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3266957

  • 1. Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP.
    Kopin IJ, Bankiewicz KS, Harvey-White J.
    Neuropsychopharmacology; 1988 May; 1(2):119-25. PubMed ID: 3266957
    [Abstract] [Full Text] [Related]

  • 2. Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administration.
    Kopin IJ, Bankiewicz K, Harvey-White J.
    Life Sci; 1988 May; 43(2):133-41. PubMed ID: 3260652
    [Abstract] [Full Text] [Related]

  • 3. A new approach to biochemical evaluation of brain dopamine metabolism.
    Kopin IJ, White JH, Bankiewicz K.
    Cell Mol Neurobiol; 1988 Jun; 8(2):171-9. PubMed ID: 3044592
    [Abstract] [Full Text] [Related]

  • 4. Plasma homovanillic acid as an index of brain dopamine metabolism: enhancement with debrisoquin.
    Sternberg DE, Heninger GR, Roth RH.
    Life Sci; 1983 May 23; 32(21):2447-52. PubMed ID: 6855448
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the central dopaminergic index of plasma HVA in schizophrenia.
    Amin F, Davidson M, Kahn RS, Schmeidler J, Stern R, Knott PJ, Apter S.
    Schizophr Bull; 1995 May 23; 21(1):53-66. PubMed ID: 7770741
    [Abstract] [Full Text] [Related]

  • 6. Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.
    Riddle MA, Leckman JF, Cohen DJ, Anderson M, Ort SI, Caruso KA, Shaywitz BA.
    J Neural Transm; 1986 May 23; 67(1-2):31-43. PubMed ID: 3465864
    [Abstract] [Full Text] [Related]

  • 7. Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.
    Maas JW, Contreras SA, Seleshi E, Bowden CL.
    Arch Gen Psychiatry; 1988 Jun 23; 45(6):553-9. PubMed ID: 3377641
    [Abstract] [Full Text] [Related]

  • 8. Relationship between plasma and cerebrospinal fluid norepinephrine and dopamine metabolites in a nonhuman primate.
    Greene KA, Faull KF.
    J Neurochem; 1989 Oct 23; 53(4):1007-13. PubMed ID: 2769251
    [Abstract] [Full Text] [Related]

  • 9. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS, LeWitt PA, Ebert MH, Pakkenberg H, Kopin IJ.
    N Engl J Med; 1985 May 30; 312(22):1418-21. PubMed ID: 2581135
    [Abstract] [Full Text] [Related]

  • 10. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
    Miller AL, Maas JW, Contreras S, Seleshi E, True JE, Bowden C, Castiglioni J.
    Biol Psychiatry; 1993 Aug 01; 34(3):178-87. PubMed ID: 8104509
    [Abstract] [Full Text] [Related]

  • 11. Dexamethasone increases plasma HVA but not MHPG in normal humans.
    Wolkowitz OM, Sutton ME, Doran AR, Labarca R, Roy A, Thomas JW, Pickar D, Paul SM.
    Psychiatry Res; 1985 Oct 01; 16(2):101-9. PubMed ID: 3865250
    [Abstract] [Full Text] [Related]

  • 12. Plasma homovanillic acid and performance on motor and cognitive tasks in community-dwelling elderly: MacArthur studies of successful aging.
    Amin F, Seeman TE, Mohs RC, Davidson M, Knott P, Berkman LF, Albert M, Blazer D.
    Neuropsychopharmacology; 1994 Feb 01; 10(1):29-35. PubMed ID: 8179792
    [Abstract] [Full Text] [Related]

  • 13. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity.
    Lambert GW, Eisenhofer G, Cox HS, Horne M, Kalff V, Kelly M, Jennings GL, Esler MD.
    Life Sci; 1991 Feb 01; 49(15):1061-72. PubMed ID: 1895870
    [Abstract] [Full Text] [Related]

  • 14. Influence of dopamine agonists on plasma and brain levels of homovanillic acid.
    Kendler KS, Heninger GR, Roth RH.
    Life Sci; 1982 Jun 14; 30(24):2063-9. PubMed ID: 7109836
    [Abstract] [Full Text] [Related]

  • 15. Effects of debrisoquin on CSF and plasma HVA concentrations in man.
    Maas JW, Contreras SA, Bowden CL, Weintraub SE.
    Life Sci; 1985 Jun 03; 36(22):2163-70. PubMed ID: 3999921
    [Abstract] [Full Text] [Related]

  • 16. Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin.
    Swann AC, Maas JW, Hattox SE, Landis H.
    Life Sci; 1980 Nov 17; 27(20):1857-62. PubMed ID: 7193269
    [No Abstract] [Full Text] [Related]

  • 17. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
    Hovevey-Sion D, Kopin IJ, Stull RW, Goldstein DS.
    Neuropharmacology; 1989 Aug 17; 28(8):791-7. PubMed ID: 2506486
    [Abstract] [Full Text] [Related]

  • 18. Plasma dopamine-beta-hydroxylase, HVA, MHPG, and conduct disorder in emotionally disturbed boys.
    Rogeness GA, Javors MA, Maas JW, Macedo CA, Fischer C.
    Biol Psychiatry; 1987 Sep 17; 22(9):1158-62. PubMed ID: 3651534
    [No Abstract] [Full Text] [Related]

  • 19. Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.
    Di Paolo T, Bédard P, Daigle M, Boucher R.
    Brain Res; 1986 Aug 06; 379(2):286-93. PubMed ID: 2427166
    [Abstract] [Full Text] [Related]

  • 20. Diurnal changes in dopamine-beta-hydroxylase, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in serum of man.
    Markianos E, Backman H.
    J Neural Transm; 1976 Aug 06; 39(1-2):79-93. PubMed ID: 988114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.